Company Valuation: Diamond Biofund Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2022 2023 2024 2025
Market Cap 1 48,069 41,446 27,810 14,058
Change - -13.78% -32.9% -49.45%
Enterprise Value (EV) 1 37,335 31,928 22,798 10,260
Change - -14.48% -28.59% -55%
P/E 62x -14.7x -11x -12x
PBR 4.35x 3.22x 2.68x 1.53x
PEG -0.9x 0x 1x 0.2x
Capitalization / Revenue 47.3x -17x -12.5x -13.1x
EV / Revenue 36.8x -13.1x -10.2x -9.56x
EV / EBITDA 41.3x -12.3x -9.53x -8.45x
EV / EBIT 41.4x -12.3x -9.5x -8.4x
EV / FCF 69.9x -18.8x -17x -11.7x
FCF Yield 1.43% -5.33% -5.9% -8.54%
Dividend per Share 2 0.1695 - - -
Rate of return 0.26% - - -
EPS 2 1.034 -3.32 -2.961 -1.38
Distribution rate 16.4% - - -
Net sales 1 1,016 -2,440 -2,229 -1,073
EBITDA 1 903.6 -2,597 -2,393 -1,214
EBIT 1 902.2 -2,598 -2,399 -1,221
Net income 1 797.8 -2,583 -2,518 -1,175
Net Debt 1 -10,734 -9,518 -5,012 -3,797
Reference price 2 64.15 48.80 32.70 16.50
Nbr of stocks (in thousands) 749,300 849,300 850,470 851,970
Announcement Date 3/24/23 2/29/24 2/26/25 3/12/26
1TWD in Million2TWD
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 430M
21.99x6x12.96x1.98% 179B
13.55x3.28x - 2.68% 142B
15.92x7.28x - 1.55% 99.99B
19.48x7.01x12.49x4.34% 93.62B
14.68x9.92x16.99x0.84% 83.52B
22.3x11.64x19.16x4.25% 75.45B
18.32x10.54x8.12x1.97% 67B
12.91x4.89x - 2.02% 47.35B
Average 17.39x 7.57x 13.94x 2.45% 87.65B
Weighted average by Cap. 17.80x 7.06x 13.83x 2.43%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Diamond Biofund Inc.

Historical PBR trend

Valuation ratios - PBR - Diamond Biofund Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Diamond Biofund Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Diamond Biofund Inc.

  1. Stock Market
  2. Stocks
  3. 6901 Stock
  4. Valuation Diamond Biofund Inc.